ID

23694

Beschreibung

Effect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00668642

Link

https://clinicaltrials.gov/show/NCT00668642

Stichworte

  1. 10.07.17 10.07.17 -
Hochgeladen am

10. Juli 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Prostate Cancer NCT00668642

Eligibility Prostate Cancer NCT00668642

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically proven prostate cancer
Beschreibung

ID.1

Datentyp

boolean

Alias
UMLS CUI [1]
C0007112
patients are hormone-naive
Beschreibung

ID.2

Datentyp

boolean

Alias
UMLS CUI [1]
C0019932
patients either to begin androgen ablation therapy with lhrh agonist or already receiving therapy with lhrh agonist
Beschreibung

ID.3

Datentyp

boolean

Alias
UMLS CUI [1]
C1298673
advanced prostate cancer with either positive pelvic nodes or bone/visceral metastasis
Beschreibung

ID.4

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0376358
UMLS CUI [1,2]
C0027627
must have an intact prostate (no previous surgery or xrt)
Beschreibung

ID.5

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0033572
UMLS CUI [1,2]
C0436209
UMLS CUI [1,3]
C0038895
ecog performance status 0-2
Beschreibung

ID.6

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
recovery from any major infection or surgical procedure
Beschreibung

ID.7

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0543467
UMLS CUI [1,2]
C2004454
UMLS CUI [1,3]
C3714514
signed informed consent
Beschreibung

ID.8

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
known intolerance or allergy to dutasteride
Beschreibung

ID.9

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0754659
concomitant chemotherapy, biologic therapy, or xrt to prostate
Beschreibung

ID.10

Datentyp

boolean

bilateral orchiectomy
Beschreibung

ID.11

Datentyp

boolean

Alias
UMLS CUI [1]
C0007347
prior malignancy within 5 years of registration
Beschreibung

ID.12

Datentyp

boolean

Alias
UMLS CUI [1]
C0455471

Ähnliche Modelle

Eligibility Prostate Cancer NCT00668642

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
histologically proven prostate cancer
boolean
C0007112 (UMLS CUI [1])
ID.2
Item
patients are hormone-naive
boolean
C0019932 (UMLS CUI [1])
ID.3
Item
patients either to begin androgen ablation therapy with lhrh agonist or already receiving therapy with lhrh agonist
boolean
C1298673 (UMLS CUI [1])
ID.4
Item
advanced prostate cancer with either positive pelvic nodes or bone/visceral metastasis
boolean
C0376358 (UMLS CUI [1,1])
C0027627 (UMLS CUI [1,2])
ID.5
Item
must have an intact prostate (no previous surgery or xrt)
boolean
C0033572 (UMLS CUI [1,1])
C0436209 (UMLS CUI [1,2])
C0038895 (UMLS CUI [1,3])
ID.6
Item
ecog performance status 0-2
boolean
C1520224 (UMLS CUI [1])
ID.7
Item
recovery from any major infection or surgical procedure
boolean
C0543467 (UMLS CUI [1,1])
C2004454 (UMLS CUI [1,2])
C3714514 (UMLS CUI [1,3])
ID.8
Item
signed informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
ID.9
Item
known intolerance or allergy to dutasteride
boolean
C0020517 (UMLS CUI [1,1])
C0754659 (UMLS CUI [1,2])
ID.10
Item
concomitant chemotherapy, biologic therapy, or xrt to prostate
boolean
ID.11
Item
bilateral orchiectomy
boolean
C0007347 (UMLS CUI [1])
ID.12
Item
prior malignancy within 5 years of registration
boolean
C0455471 (UMLS CUI [1])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video